The legacy of UW Chancellor John Wiley is not confined to the UW-Madison campus, but throughout the state of Wisconsin, according to columnist Tom Still. In this edition of Inside Wisconsin, Still notes that Wisconsin businesses and campuses throughout the state, particularly UW-Milwaukee, have had...
Clinicians lack a non-invasive way to detect invading brain tumor cells, which is one of the reasons that brain tumors are such a death sentence. No organization understands this more than the National Cancer Institute, which has awarded the Medical College of Wisconsin a $333,300...
Is “Return of the Dotcom Bust” coming to a business theater near you? Columnist Brad Spirrison thinks the $15 billion valuation for Facebook could be a prelude to a second "dot-comedy," and he quotes several venture capitalists that view this level of valuation as an...
Innovation, and the value-added products and services that result, has been touted far and wide as the antidote to low-price competition from India and China, and it is one of the reasons why Wisconsin Gov. Jim Doyle is pushing incentives for research and development. However,...
Legislation known as the Cable Competition Bill now has passed both houses of the Wisconsin Legislature and is on its way to Gov. Jim Doyle's desk. The bill would end existing deals between local governments and cable companies, and establish a statewide franchise for service...
Is there a control mechanism that allows computer programmers into production while still providing some assurance that they are not accidentally jeopardizing (or intentionally manipulating) software? You bet there is, and Jerry Norton explains it in this edition of Boardroom Perspectives. According to Norton, the...
The next decade will be a good time to be a network system and data communications professional, but not so good to be a computer operator or programmer, according to the 10-year economic and employment predictions released by the Bureau of Labor Statistics. The overall...
Unless you regularly are involved in venture capital transactions and stay up to date on recent trends and deal structures, it's hard to know if you're taking advantage of best industry practices. Attorney and columnist Matt Storms has a handy resource, the American Bar Association's...
The high cost of developing prescription drugs has started a race to make pharmaceutical products more affordable, and venture capitalists are placing bets on the outcome. CDI Bioscience, a Madison-based company that has developed a technology to boost protein production and lower drug-manufacturing costs, will...
Third Wave Technologies, a Madison-based research molecular diagnostics company, has received a $25 million line of credit from Deerfield Management. The additional capital will support the execution of long-range plans for the human papilloma virus and the hospital lab markets. ...